ImmuCell Stock

ImmuCell Debt 2024

ImmuCell Debt

10.99 USD

Ticker

ICCC

ISIN

US4525253062

WKN

885825

In 2024, ImmuCell's total debt was 10.99 USD, a 147.54% change from the 4.44 USD total debt recorded in the previous year.

ImmuCell Aktienanalyse

What does ImmuCell do?

ImmuCell Corp is an American company that specializes in the development and marketing of veterinary products for the ruminant industry. It was originally founded in the late 1970s under the name PrioGene and initially focused on the development of diagnostics for tuberculosis and brucellosis in cattle. In the 1990s, the company changed its name to ImmuCell and shifted its focus to the development of products to support animal health. ImmuCell's business model is centered around the development, manufacturing, and sale of products to improve animal health. They offer a wide range of veterinary products, including immunoassays, vaccines, antibiotics, and complementary feeds. The company aims to improve animal health with minimal impact on the environment and works closely with veterinarians and industry experts. They have divisions dedicated to diagnostics, vaccines, and antibiotics, and their products can help identify and prevent diseases in livestock. Notable products include the LBC mastitis diagnostic and the Immu-PRIME spray for preventing umbilical infections in newborn calves. ImmuCell has established itself as a leading innovator in the animal health industry and has conducted clinical studies on the efficacy of their HO-VAX product. In conclusion, ImmuCell focuses on developing and marketing products to support animal health, with a commitment to improving the well-being of livestock. ImmuCell ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding ImmuCell's Debt Structure

ImmuCell's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing ImmuCell's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to ImmuCell’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in ImmuCell’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about ImmuCell stock

What is the debt of ImmuCell this year?

ImmuCell has a debt level of 10.99 USD this year.

What was the debt of ImmuCell compared to the previous year?

The debt of ImmuCell has increased by 147.54% compared to the previous year increased.

What are the consequences of high debt for investors in ImmuCell?

High debt can pose a risk for investors of ImmuCell, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of ImmuCell?

Low debt means that ImmuCell has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from ImmuCell affect the company?

An increase in debt of ImmuCell can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of ImmuCell affect the company?

A reduction in debt of ImmuCell can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of ImmuCell?

Some factors that can influence the debt of ImmuCell include investments, acquisitions, operating costs, and revenue development.

Why are the debts of ImmuCell so important for investors?

The debts of ImmuCell are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can ImmuCell take to change the debt?

To change the debt, ImmuCell can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does ImmuCell pay?

Over the past 12 months, ImmuCell paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ImmuCell is expected to pay a dividend of 0 USD.

What is the dividend yield of ImmuCell?

The current dividend yield of ImmuCell is .

When does ImmuCell pay dividends?

ImmuCell pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ImmuCell?

ImmuCell paid dividends every year for the past 0 years.

What is the dividend of ImmuCell?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ImmuCell located?

ImmuCell is assigned to the 'Health' sector.

Wann musste ich die Aktien von ImmuCell kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ImmuCell from 10/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2024.

When did ImmuCell pay the last dividend?

The last dividend was paid out on 10/8/2024.

What was the dividend of ImmuCell in the year 2023?

In the year 2023, ImmuCell distributed 0 USD as dividends.

In which currency does ImmuCell pay out the dividend?

The dividends of ImmuCell are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ImmuCell

Our stock analysis for ImmuCell Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ImmuCell Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.